Compare DexCom, Inc. (DXCM) vs Schlumberger NV (SLB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
DexCom, Inc. vs Schlumberger NV — how do they compare? DexCom, Inc. trades at $89.2 (market cap $33.79B), while Schlumberger NV trades at $53.7 (market cap $79.67B). The key difference: Schlumberger NV is far larger — about 2.4× DexCom, Inc.'s market cap, and Schlumberger NV pays a 2.2% dividend while DexCom, Inc. pays none. Which is the better fit depends on your goals.
| DXCM | SLB | |
|---|---|---|
Market Cap | $33.79B | $79.67B |
Sector | Health | Energy |
52-Week High | $89.53 | $58.01 |
52-Week Low | $54.84 | $31.72 |
Enterprise Value | $33.24B | $88.40B |
Dividend Yield | — | 2.2% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About DexCom, Inc.
Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.
Read more on DXCM →About Schlumberger NV
Schlumberger is the largest oilfield service firm in the world, with expertise in myriad disciplines, including reservoir performance, well construction, production enhancement, and more recently, digital solutions. It maintains a reputation as one of the industry's leading innovators, which has earned it dominant share in numerous end markets.
Read more on SLB →
